Charles Elcan Increases Stake in REX American Resources

Charles Elcan bought 4,423 shares of REX American Resources, showing confidence in the company.

Key Points

  • Charles Elcan purchased 4,423 shares of REX American Resources on June 15, 2026.
  • REX American Resources, trading at $43.68, has a market cap of $1.44 billion and a P/E ratio of 15.6.
  • Insider buying also included CFO Douglas Bruggeman and others, while analysts maintain a 'buy' rating.

Charles Elcan recently purchased 4,423 shares of REX American Resources Corporation (NYSE: REX) on June 15, 2026. This insider buy comes as the stock is trading at $43.68 per share. Elcan's move is part of a series of insider transactions that day, reflecting potential confidence in the company's future performance.

Insider Buying and Selling at REX American Resources Corporation

In addition to Charles Elcan, other insiders also engaged in transactions on June 15, 2026. Douglas Bruggeman, the CFO, VP-Finance, and Treasurer, bought 49,266 shares. Anne Macmillan, Cheryl Lea Bustos, Edward Kress, and Mervyn Alphonso each purchased 4,423 shares. Meanwhile, Stuart Rose, the Executive Chairman of the Board, sold 19,211 shares at an average price of $42.97.

Other Institutional Activity in REX American Resources

Several institutional investors have been adjusting their positions in REX American Resources. BlackRock, Inc. trimmed its holdings by 4,657 shares, leaving it with 5,493,426 shares valued at about $250.3 million. Dimensional Fund Advisors LP reduced its stake by 68,153 shares, ending with 1,896,068 shares worth approximately $86.4 million. Renaissance Technologies LLC also cut its position by 72,036 shares, holding 1,523,594 shares valued at $69.4 million. In contrast, State Street Corp increased its holdings by 109,786 shares to a total of 1,453,113 shares, valued at $66.2 million. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both established new positions, each holding over 1.2 million shares.

REX American Resources Stock Snapshot

Shares of REX American Resources are currently trading near $43.68. The company boasts a market cap of approximately $1.44 billion and a P/E ratio of 15.6. It has a beta of 0.613, indicating lower volatility compared to the market. The stock's 52-week range is between $23.82 and $53.36, with a 50-day moving average of $46.77 and a 200-day moving average of $37.22. The company maintains a strong financial position with a current ratio of 6.76 and a quick ratio of 6.073.

Recent Earnings

REX American Resources reported revenue of $656.2 million, showing a growth of 3.6%. The company achieved a net margin of 14.1% and a return on equity of 15.8%. Earnings per share stood at $2.80. Investors will be looking forward to the next earnings release scheduled for August 26, 2026.

Analysts Set New Price Targets

Analysts have shown optimism towards REX American Resources. On March 27, 2025, Truist Securities reiterated its 'buy' rating with a price target of $50. The consensus among analysts suggests a positive outlook, with a recommendation key of 'buy' and a mean target price that indicates potential upside.

About REX American Resources

REX American Resources Corporation, based in Dayton, Ohio, is involved in producing and selling ethanol and related products in the United States. The company, led by CEO Mr. Zafar A. Rizvi, operates within the chemicals industry and produces corn, distillers grains, ethanol, and other related products. Founded in 1980, REX employs 132 people and continues to innovate in the basic materials sector.

Bottom Line

Charles Elcan's recent purchase of REX American Resources shares adds to the insider activity observed on June 15. Investors often track such transactions as they can indicate insider confidence in the company's prospects. However, it's important to remember that these insider trades are disclosed after the fact and may not reflect current positions.

See Also

This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.